CBDRx has developed a unique, proprietary strain of hemp after extensive genetic testing and breeding of various hemp cultivars, achieving a plant rich in high levels of cannibidiol (CBD) and a broad spectrum of cannabinoids, high terpenes, and very low THC. While most industrial hemp cultivars contain CBD at only 2-4% by weight, CBDRx cannabinoid levels average 12-14%.
Tissue Culture Cloning
Using protocols developed by our agronomists, we are developing specific strains, which have been grown, flowered and tested at all stages of development to produce up to 100,000 female replicas, or clones, of our high quality female hemp cultivars. These clones begin the maturation process first inside our R&D facility, then in compliant greenhouses and are finally planted on our Pueblo Farm until harvested for extraction and raw material ingredient usage.
Our agronomists use a protocol of select organic humates, zeolites and microbial, tailored in their composition and ratios to the properties of our farm's soil, water and air as determined through testing to create the optimal nutrient-rich environment. Our soil amendment and fertilization protocol allows for a cost effective, robust and consistent plant yield achieving a large-scale cultivation of high-quality viable hemp in Colorado's outdoor environment.
Agriculture's CBD Future
Although the U.S. hemp market is estimated to be approaching $1 billion, whereas the U.S. medical marijuana market is estimated to be $20 billion, CBD/cannabinoid-rich oils appear to be becoming the fastest growing segment within the U.S. As hemp continues its inroad into our culture, we anticipate that CBD/cannabinoid extractions from medicinal hemp will be Agriculture's next big window of opportunity and Colorado's next frontier. We predict CBD and the other cannabinoids will revolutionize agriculture as much as medicine.